Study on best treatment for bleeding under the retina
Part of Eyes & vision clinical trials.
This trial looks at whether the type of abnormal blood vessels under the retina affects how well a procedure (pneumatic displacement) works to move a macular hemorrhage (bleeding) out of the central vision area. It may help doctors choose the best approach for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years or older
- You are white (Caucasian)
- You have a recent bleeding under the retina (within 36 hours) caused by abnormal blood vessels (macular neovascularization)
- The bleeding is at least the size of a small finger tip and located in the central vision area
- You have not had this same procedure before in the affected eye
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special laser (photobiomodulation) can help slow or improve vision loss from reticular pseudodrusen, a specific type of retinal damage seen in age-related macular degeneration. The laser delivers safe light energy to stimulate healing in the eye.
This trial tests a refillable eye implant (PDS) that slowly releases medication to treat wet age-related macular degeneration (nAMD). It aims to see if replacing the implant every 36 weeks works as well as regular eye injections.
This trial tests whether a specific eye surgery plus targeted clot-busting medicine and gas can improve vision after bleeding under the retina from “wet” age-related macular degeneration. It aims to reduce how long the bleeding lasts and help protect the central vision.
This trial tests a new treatment for people with a hard-to-treat form of wet age-related macular degeneration (AMD) that has not improved with standard anti-VEGF injections. It aims to stop the disease from getting worse and possibly improve vision.
This trial tests whether switching from anti-VEGF injections to a special laser is better than continuing injections alone for people with diabetic macular edema whose central retinal thickness has dropped below 400 microns after the first year of treatment.
This study compares ten different surgical methods for repairing full-thickness macular holes—small breaks in the central part of the retina that blur vision. You'd be in the study to help doctors learn which technique works best at restoring sight.
Hear when a new AMD - Age-Related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.